Skip to content
Screener

Cytek Biosciences, Inc. CTKB Other — Total revenue, net

Other geography segments

EMEA
$11.3M-8.2%
APAC
$7.92M+0.6%

Similar metrics at other companies

Coupang logo
CPNGOther revenue — Total net revenues
$261M+1.2%
Coupang logo
CPNGNet other revenue — Total net revenues
$2.03B+11.4%
Sotera Health logo
SHCOther — Total net revenues
$19.99M+1.4%
HP logo
HPQOther countries — Total net revenue
$9.02B+3.8%
Autodesk logo
ADSKOther Americas — Total net revenue
$162M+15.7%
Viavi Solutions Inc. logo
VIAVOther Americas — Total net revenue
$28.8M+58.2%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$28,220$23,894$52,607$42,429
EMEA11,30412,30922,06923,875
APAC7,9157,86715,66616,758
Other7011,5321,9333,997
Total revenue, net$48,140$45,602$92,275$87,059

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s other — total revenue, net?
Cytek Biosciences, Inc. (CTKB) reported other — total revenue, net of $701K in Q2 2026.
How has Cytek Biosciences, Inc.'s other — total revenue, net changed year-over-year?
Cytek Biosciences, Inc.'s other — total revenue, net decreased by 54.2% year-over-year, from $1.53M to $701K.
What is the long-term trend for Cytek Biosciences, Inc.'s other — total revenue, net?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s other — total revenue, net has grown at a -48.1% compound annual growth rate (CAGR), from $127.95M to $9.28M.
What does other — total revenue, net mean?
This metric represents the net revenue generated from business activities, products, or geographic regions that do not fall under the company's primary reporting segments. It captures income from ancillary operations or non-core markets that contribute to the overall top-line performance. Monitoring this figure helps investors assess the scale and growth trajectory of secondary business lines outside of the company's main strategic focus.

Ask your AI about Cytek Biosciences, Inc.'s other — total revenue, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude